XKRX
380550
, Last price
KRW
Name
Neurophet Inc
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Neurophet Inc. is a neuroscience company focused on developing cutting-edge medical artificial intelligence solutions for the study and treatment of brain conditions. Its array of offerings includes Neurophet AQUA, an AI-powered diagnostic aid for identifying brain diseases, and Neurophet SCALE PET, software for precisely analyzing biomarkers detected by specific radiotracers in PET imaging. The firm also provides Neurophet tES LAB, an AI-driven platform that generates 3D brain models from MRI scans to simulate electrical stimulation for therapeutic planning. Additionally, Neurophet produces Neurophet innk, a non-invasive electrical stimulation device designed to support functional recovery and rehabilitation for individuals with neurological disorders. Complementing these products, Neurophet offers consulting services for design and quality management systems. This company was established in 2016 and is headquartered in Seoul, South Korea.
Key people
Dong Hyeon Kim
Chief Technology Officer
Valuation
No data to show